Close

Repros Therapeutics (RPRX) Announces Significant Pooled Data from Proellex Phase 2s in Uterine Fibroids

Go back to Repros Therapeutics (RPRX) Announces Significant Pooled Data from Proellex Phase 2s in Uterine Fibroids